Home
>
National Drug Code (NDC)
>
Ery
Ery - 45802-962-72 - (Erythromycin)
Drug Information of Ery
| Product NDC: | 45802-962 |
| Proprietary Name: | Ery |
| Non Proprietary Name: | Erythromycin |
| Active Ingredient(s): | .8 mL/100mL & nbsp; Erythromycin |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ery
| Product NDC: | 45802-962 |
| Labeler Name: | Perrigo New York Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA064126 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080707 |
Package Information of Ery
| Package NDC: | 45802-962-72 |
| Package Description: | 60 APPLICATOR in 1 JAR (45802-962-72) > .8 mL in 1 APPLICATOR |
NDC Information of Ery
| NDC Code | 45802-962-72 |
| Proprietary Name | Ery |
| Package Description | 60 APPLICATOR in 1 JAR (45802-962-72) > .8 mL in 1 APPLICATOR |
| Product NDC | 45802-962 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Erythromycin |
| Dosage Form Name | SOLUTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20080707 |
| Marketing Category Name | ANDA |
| Labeler Name | Perrigo New York Inc |
| Substance Name | ERYTHROMYCIN |
| Strength Number | .8 |
| Strength Unit | mL/100mL |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
